U.S. Biotech Companies Outpace European Counterparts In Funding, Report Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The U.S. biotech industry received 81% of total equity and debt funding raised by biotechs in 2004 despite having fewer companies than Europe, Critical I consulting firm finds.